Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Brinkman

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|August 23, 2011
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSMFemke A E Lambers, Maria Prins, Xiomara Thomas, et al.
AIDS (London, England)|December 23, 2015
Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the NetherlandsEsther A N Engelhard, Colette Smit, Ard Van Sighem, et al.
Antiviral Therapy|January 30, 2003
Hyperlactataemia in HIV-infected patients: the role of NRTI-treatmentSaskia M E Vrouenraets, Marco Treskes, Rosa M Regez, et al.
BMJ (Clinical Research Ed.)|April 9, 2005
Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3Gerard J B Sonder, Rosa M Regez, Kees Brinkman, et al.
AIDS (London, England)|November 9, 2016
Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practiceMark G J de Boer, Guido E L van den Berk, Natasja van Holten, et al.
BMJ Open|January 6, 2016
Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohortEline L M Op de Coul, Ard van Sighem, Kees Brinkman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2017
High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the NetherlandsAnne Boerekamps, Astrid M Newsum, Colette Smit, et al.
AIDS (London, England)|June 3, 2009
Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The NetherlandsMarion Cornelissen, Frederik M Hoogland, Nicole K T Back, et al.
AIDS and Behavior|March 31, 2021
Understanding Reasons for HIV Late Diagnosis: A Qualitative Study Among HIV-Positive Individuals in Amsterdam, The NetherlandsMaarten Bedert, Udi Davidovich, Godelieve de Bree, et al.
AIDS (London, England)|June 24, 2003
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individualsDavid Burger, Patricia Hugen, Peter Reiss, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|August 23, 2011
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSMFemke A E Lambers, Maria Prins, Xiomara Thomas, et al.
AIDS (London, England)|December 23, 2015
Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the NetherlandsEsther A N Engelhard, Colette Smit, Ard Van Sighem, et al.
Antiviral Therapy|January 30, 2003
Hyperlactataemia in HIV-infected patients: the role of NRTI-treatmentSaskia M E Vrouenraets, Marco Treskes, Rosa M Regez, et al.
BMJ (Clinical Research Ed.)|April 9, 2005
Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3Gerard J B Sonder, Rosa M Regez, Kees Brinkman, et al.
AIDS (London, England)|November 9, 2016
Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practiceMark G J de Boer, Guido E L van den Berk, Natasja van Holten, et al.
BMJ Open|January 6, 2016
Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohortEline L M Op de Coul, Ard van Sighem, Kees Brinkman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2017
High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the NetherlandsAnne Boerekamps, Astrid M Newsum, Colette Smit, et al.
AIDS (London, England)|June 3, 2009
Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The NetherlandsMarion Cornelissen, Frederik M Hoogland, Nicole K T Back, et al.
AIDS and Behavior|March 31, 2021
Understanding Reasons for HIV Late Diagnosis: A Qualitative Study Among HIV-Positive Individuals in Amsterdam, The NetherlandsMaarten Bedert, Udi Davidovich, Godelieve de Bree, et al.
AIDS (London, England)|June 24, 2003
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individualsDavid Burger, Patricia Hugen, Peter Reiss, et al.
Pageof 10